Alpha-santalol, a chemopreventive agent against skin cancer, causes G 2/M cell cycle arrest in both p53-mutated human epidermoid carcinoma A431 cells and p53 wild-type human melanoma UACC-62 cells

BMC Research Notes

Volumn 3, Issue , 2010, Pages

  Zhang, Xiaoying ^a   Chen, Wei ^b   Guillermo, Ruth ^b   Chandrasekher, Gudiseva ^b   Kaushik, Radhey S ^b   Young, Alan ^b   Fahmy, Hesham ^b   Dwivedi, Chandradhar ^b  

^a Shanghai ChemPartner Co Ltd   (China)

^b SOUTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MURINAE; SANTALUM;

EID: 77955891544     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-3-220     Document Type: Article

References (36)

1. Cancer Facts and Figures. American Cancer Society 2009 http://www.cancer.org
2. Cancer prevention - the potential for diet to modulate molecular signalling. MM Manson, Trends Mol Med 2003 9 11 18 10.1016/S1471-4914(02)00002-3 12524205
3. Suppression of tumour development by substances derived from the diet - mechanisms and clinical implications. A Gescher U Pastorino SM Plummer MM Manson, Br J Clin Pharmacol 1998 45 1 12 10.1046/j.1365-2125.1998.00640.x 9489587
4. Cancer chemoprevention with dietary phytochemicals. YJ Surh, Nat Rev Cancer 2003 3 768 780 10.1038/nrc1189 14570043
5. Chemopreventive activity of parthenolide against UVB-induced skin cancer and its mechanisms. YK Won CN Ong X Shi HM Shen, Carcinogenesis 2004 25 1449 1458 10.1093/carcin/bgh151 15033901
6. Skin cancer chemoprevention: strategies to save our skin. JG Einspahr GT Bowden DS Alberts, Recent Results Cancer Res 2003 163 151 164 discussion 264-156 12903851
7. Chemoprevention of nonmelanoma skin cancer: experience with a polyphenol from green tea. KG Linden PM Carpenter CE McLaren RJ Barr P Hite JD Sun KT Li JL Viner FL Meyskens, Recent Results Cancer Res 2003 163 165 171 discussion 264-166 12903852
8. Chemopreventive effects of alpha-santalol on skin tumor development in CD-1 and SENCAR mice. C Dwivedi X Guan WL Harmsen AL Voss DE Goetz-Parten EM Koopman KM Johnson HB Valluri DP Matthees, Cancer Epidemiol Biomarkers Prev 2003 12 151 156 12582025 (Pubitemid 36194005)
9. Chemopreventive effects of alpha-santalol on ultraviolet B radiation-induced skin tumor development in SKH-1 hairless mice. C Dwivedi HB Valluri X Guan R Agarwal, Carcinogenesis 2006 27 1917 1922 10.1093/carcin/bgl058 16679309 (Pubitemid 44288673)
10. Chemoprevention by alpha-santalol on UVB radiation-induced skin tumor development in mice. A Bommareddy J Hora B Cornish C Dwivedi, Anticancer Res 2007 27 2185 2188 17695502 (Pubitemid 47228052)
11. Effects of alpha-santalol on proapoptotic caspases and p53 expression in UVB irradiated mouse skin. BL Arasada A Bommareddy XY Zhang K Bremmon C Dwivedi, Anticancer Res 2008 28 129 132 18383835
12. Skin cancer chemopreventive agent, alpha-santalol, induces apoptotic death of human epidermoid carcinoma A431 cells via caspase activation together with dissipation of mitochondrial membrane potential and cytochrome c release. M Kaur C Agarwal RP Singh XM Guan C Dwivedi R Agarwal, Carcinogenesis 2005 26 369 380 10.1093/carcin/bgh325 15528219
13. Cell cycle control as a basis for cancer chemoprevention through dietary agents. SM Meeran SK Katiyar, Front Biosci 2008 13 2191 2202 10.2741/2834 17981702
14. Evaluation of the quality of sandalwood essential oils by gas chromatography-mass spectrometry. MJ Howes MS Simmonds GC Kite, J Chromatogr A 2004 1028 307 312 10.1016/j.chroma.2003.11.093 14989484
15. Sarcophine-diol, a Chemopreventive Agent of Skin Cancer, Inhibits Cell Growth and Induces Apoptosis through Extrinsic Pathway in Human Epidermoid Carcinoma A431 Cells. X Zhang A Bommareddy W Chen S Khalifa RS Kaushik H Fahmy C Dwivedi, Transl Oncol 2009 2 21 30 19252748
16. Regulation of cell cycle transition and induction of apoptosis in HL-60 leukemia cells by lipoic acid: role in cancer prevention and therapy. E Selvakumar TC Hsieh, J Hematol Oncol 2008 1 4 10.1186/1756-8722-1-4 18577252
17. Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines. DJ Park H Nakamura AM Chumakov JW Said CW Miller DL Chen HP Koeffler, Oncogene 1994 9 1899 1906 8208536
18. Mutant p53-dependent growth suppression distinguishes PRIMA-1 from known anticancer drugs: a statistical analysis of information in the National Cancer Institute database. VJ Bykov N Issaeva G Selivanova KG Wiman, Carcinogenesis 2002 23 2011 2018 10.1093/carcin/23.12.2011 12507923
19. Regulating mammalian checkpoints through Cdc25 inactivation. M Donzelli GF Draetta, EMBO Rep 2003 4 671 677 10.1038/sj.embor.embor887 12835754
20. The anthelmintic drug mebendazole induces mitotic arrest and apoptosis by depolymerizing tubulin in non-small cell lung cancer cells. J Sasaki R Ramesh S Chada Y Gomyo JA Roth T Mukhopadhyay, Mol Cancer Ther 2002 1 1201 1209 12479701
21. Heterocyclic organobismuth(III) compound targets tubulin to induce G2/M arrest in HeLa cells. K Iuchi K Akagi T Yagura, J Pharmacol Sci 2009 109 573 582 10.1254/jphs.09020FP 19352070
22. Cell cycle control and cancer. LH Hartwell MB Kastan, Science 1994 266 1821 1828 10.1126/science.7997877 7997877
23. Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer. RJ Michalides, J Clin Pathol 1999 52 555 568 10.1136/jcp.52.8.555 10645224
24. Correlations of cell cycle regulators (p53, p21, pRb and mdm2) and c-erbB-2 with biological markers of proliferation and overall survival in breast cancer. AE Pinto S Andre C Laranjeira J Soares, Pathology 2005 37 45 50 10.1080/00313020400011250 15875733
25. The role of cell cycle regulatory proteins in the pathogenesis of melanoma. W Li A Sanki RZ Karim JF Thompson C Soon Lee L Zhuang SW McCarthy RA Scolyer, Pathology 2006 38 287 301 10.1080/00313020600817951 16916716
26. Inhibitors of mammalian G1 cyclin-dependent kinases. CJ Sherr JM Roberts, Genes Dev 1995 9 1149 1163 10.1101/gad.9.10.1149 7758941
27. Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis. IB Weinstein, Carcinogenesis 2000 21 857 864 10.1093/carcin/21.5. 857 10783304
28. Microtubule-damaging agents enhance RASSF1A-induced cell death in lung cancer cell lines. YM Whang KH Park HY Jung UH Jo YH Kim, Cancer 2009 115 1253 1266 10.1002/cncr.24113 19156899
29. Dose-dependent effects of stable cyclin B1 on progression through mitosis in human cells. F Wolf C Wandke N Isenberg S Geley, EMBO J 2006 25 2802 2813 10.1038/sj.emboj.7601163 16724106
30. Diallyl disulfide induces reversible G2/M phase arrest on a p53-independent mechanism in human colon cancer HCT-116 cells. HJ Jo JD Song KM Kim YH Cho KH Kim YC Park, Oncol Rep 2008 19 275 280 18097607
31. Mammalian cell cycle checkpoints: signalling pathways and their organization in space and time. J Lukas C Lukas J Bartek, DNA Repair (Amst) 2004 3 997 1007 10.1016/j.dnarep.2004.03.006 15279786
32. Cell cycle checkpoints and their impact on anticancer therapeutic strategies. A Eastman, J Cell Biochem 2004 91 223 231 10.1002/jcb.10699 14743382
33. Tetrandrine induces early G1 arrest in human colon carcinoma cells by down-regulating the activity and inducing the degradation of G1-S-specific cyclin-dependent kinases and by inducing p53 and p21Cip1. LH Meng H Zhang L Hayward H Takemura RG Shao Y Pommier, Cancer Res 2004 64 9086 9092 10.1158/0008-5472.CAN-04-0313 15604277
34. p53 regulation of G(2) checkpoint is retinoblastoma protein dependent. PM Flatt LJ Tang CD Scatena ST Szak JA Pietenpol, Mol Cell Biol 2000 20 4210 4223 10.1128/MCB.20.12.4210-4223.2000 10825186
35. The p53 pathway is synergized by p38 MAPK signaling to mediate 11,11'-dideoxyverticillin-induced G2/M arrest. Y Chen ZH Miao WM Zhao J Ding, FEBS Lett 2005 579 3683 3690 10.1016/j.febslet.2005.05.053 15963507
36. A role for p53 in the regulation of extracellular matrix metalloproteinase inducer in human cancer cells. H Zhu B Evans P O'Neill X Ren Z Xu WN Hait JM Yang, Cancer Biol Ther 2009 8 1722 1728 19597352